The AGM is on Wednesday where they will announce H1FY23 revenue guidance.
CY21 guidance was $55-$57M.
If they can make $27M from the December quarter, CY22 would be $76.1M.
Revenue is observed to be very lumpy between quarters making future revenues and overall valuation difficult to predict.
US revenues are trending up from when they acquired Adheris. Best quarter was $19.9M which was followed by the worst quarter at $7.4M - lumpy.
AU revenues also trending up with new revenues also coming from acquisitions, but meagre organic growth.
$25M to $27M quarters are probably not achievable every quarter, but they should be able to predict a revenue target where the business is CFP and at the same time understand where their spend profile makes sense for CFP.
- Forums
- ASX - By Stock
- MDR
- Ann: Quarterly Report and Appendix 4C
MDR
medadvisor limited
Add to My Watchlist
1.25%
!
7.9¢

Ann: Quarterly Report and Appendix 4C, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
7.9¢ |
Change
-0.001(1.25%) |
Mkt cap ! $49.35M |
Open | High | Low | Value | Volume |
8.0¢ | 8.0¢ | 7.9¢ | $8.243K | 103.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10060 | 7.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.3¢ | 77963 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10060 | 0.079 |
2 | 300000 | 0.078 |
1 | 100000 | 0.076 |
2 | 66500 | 0.075 |
3 | 116554 | 0.074 |
Price($) | Vol. | No. |
---|---|---|
0.083 | 77963 | 2 |
0.084 | 209999 | 3 |
0.088 | 1944 | 1 |
0.090 | 42500 | 2 |
0.091 | 100000 | 1 |
Last trade - 12.09pm 16/06/2025 (20 minute delay) ? |
Featured News
MDR (ASX) Chart |